Implications and Future Perspectives of Nanomedicine and Plant-Based Biogenic Nanoparticles (NPs) for Cancer Management

Abstract

In the modern era of science, nanotechnology has the ability to circumvent numerous disadvantages of conservative healing preparations. Important progress has been made towards the use of tailored nanomaterials (NMs) to treat the cancer with efficiency, specificity, and high sensitivity. Tailored NMs are operationalized with precise ligands that can predictably target the cancer cells and deliver encapsulated payloads meritoriously. Moreover, NMs can also be deliberated to increase the drug loading, controlled release, improved half-life, and selective distribution by altering their size, surface chemistry, composition, and morphology. The conservative cancer treatments have provoked the event and applications of nanomaterials. The emerging evidence suggests that nanomedicines will provide the next-generation stages for anticancer remedies.